The Global Drug of Abuse Testing Market is likely to register a CAGR of 5.33% and is projected to reach USD 5,067.9 million by 2025.
Drug of abuse testing is based on analyzing and detecting drug addiction and is also called substance use disorder. It requires an in-depth evaluation and often includes an assessment by a psychologist, psychiatrist, or a licensed alcohol and drug counselor. Multiple tests are conducted for blood, urine, or others which are used to evaluate drug use. These tests may be used for intensive care treatment but are not a diagnostic assessment for addiction.
The growing illegal drug trafficking for the cultivation, distribution, and manufacture of drug substances is expected to create a vast scope of opportunities for the market growth of the global drug of abuse testing market.
Key Players
The key players of the drug of abuse testing market are Quest Diagnostics (US), Laboratory Corporation of America Holdings (LabCorp) (US), Abbott Laboratories (US), Randox laboratories (UK), Bio-Rad Laboratories, Inc. (the US), Quest Diagnostics Incorporated (US), Sonic Healthcare (Australia), F. Hoffmann-La Roche Ltd (Switzerland), and Thermo Fisher Scientific, Inc. (US).
Avail FREE Sample of this Report at: https://www.marketresearchfuture.com/sample_request/1930
Several factors likely to influence the growth of the drug of abuse testing market are the augmented use of drug testing at the executive level, increase in production and trade of illegal drugs globally and others.
Segmental Analysis
The global market for drug of abuse testing has been segmented on the basis of test type and samples.
Based on the test type, the market has been segmented into the onsite screening test and laboratory drug testing.
Based on the sample, the market is segmented into hair, urine, saliva, and others.
Market Dynamics
Drug testing in the workplace has traditionally been conducted using collection and analysis of urine. Urine as a specimen for drug testing allows for a long window of detection. Drug of abuse testing has been increasingly used by the American and European organizations at various levels like pre-employment screening, random drug/alcohol screening, post-incident drug or alcohol screening, and abstinence monitoring. Testing has become mandatory for multiple national and international organizations such as the International Olympic Committee (IOC), International Sports Federation (ISF) and National Olympic Committee, to stop drug abuse in sports. Thus, the market is projected to grow at a steady rate during the forecast period.
Intended Audience
- Biopharmaceutical companies
- Government research organizations
- Hospitals and clinics
- Regulatory agencies
- Pharmaceutical companies
Browse the Full Research Report at: https://www.marketresearchfuture.com/reports/drug-abuse-testing-market-1930
Regional Analysis
The global market for drug of abuse testing is segmented into North America, Europe, Asia Pacific (APAC), and the rest of the world.
North America is the largest region in the global drug of abuse testing market and is expected to retain its market standing over the forecast period. In North America, the usage of cocaine had been witnessing a decline, partially due to a continued shortage. However, more recently, a slight increase in the prevalence of cocaine has been detected in the U.S., as there has been a rise in maritime seizures. This is expected to contribute substantially to market growth over the review period.
Europe is the second largest region in the global drug of abuse testing market and is expected to maintain its market position through the assessment period. In Europe, cannabis is the most common illegal substance. In Europe, the market has transformed over the past decade, with cannabis herb produced locally or regionally has witnessed an incline due to cannabis resin, primarily sourced from Morocco. This is expected to drive the market in Europe over the forecast period. The highest prevalence of injecting drug use globally is found in Eastern and south-eastern European countries.
The Asia Pacific is another important region of the global drug of abuse testing market and is expected to witness considerable growth over the review period. This is due to the gradually increasing usage of ecstasy, cocaine, and opiates in south Asian countries. The usage of methamphetamine is expected to rise in most of the countries in East and South-East Asia, with complementary seizures of methamphetamine in crystalline pill forms. It has been studied that in East and South-East Asia, the usage of ATS has both increased and diversified. This is expected to create a vast scope of growth opportunities in the asia pacific market for drug of abuse testing. The growing awareness among consumers and initiatives taken by the governments of developing countries such as India, China, Japan, and others, is expected to contribute substantially to the market growth in the region.
Ask for an Amazing Discount at: https://www.marketresearchfuture.com/check-discount/1930
Available Additional Customizations
- Additional Companies
- Shimadzu Corporation
- Danaher Corporation
- Siemens AG
- Merck KGaA
- Drägerwerk AG & Co. KGaA
- bioMérieux SA
- Waters Corporation
- Investment Opportunities
- Drug of Abuse Testing Market Size for Latin America, Asia-Pacific, and the Middle East and Africa
About Market Research Future: Our team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312